The SURMOUNT-1 trial evaluating tirzepatide demonstrated substantial results, with participants achieving mean weight reductions of approximately 15% (5 mg), 19.5% (10 mg), and 20.9% (15 mg) over 72 weeks
Data from the United States have indicated that semaglutide was initiated less frequently following the approval of tirzepatide, while a GlobalData forecast has predicted Mounjaro will surpass Ozempic in sales over the coming years
The investigators were granted access to the databases used to create the study population and performed several quality checks (consistency assessments, range and logic checks) before the linkage of the databases using a pseudonymised single identification number
Thats unclear and will depend on a few factors, experts say
It improves scalp health by reducing inflammation and increasing blood circulation
The majority of weight reduction is fat , increasing the proportion of lean tissue after treatment